Active Infection & Immunity Cells, Biochemistry & Physiology

How using glycans vs. proteins as receptors affects the mechanism of viral entry

In plain English

AI plain-English summary

Influenza A and coronaviruses can switch their cellular entry points from sugar molecules to proteins, and this shift alters how they infect hosts and jump between species. This matters because the type of receptor a virus uses—glycan or protein—directly affects how tightly it binds to cells and how it fuses with them to deliver its genetic material. Current knowledge of these mechanisms is limited, leaving a gap in understanding how receptor changes drive viral evolution, disease severity, and host jumps. The researcher will compare how influenza haemagglutinins and coronavirus spikes recognise and interact with both glycan and protein receptors at the molecular level, building on pilot data from bat-like influenza viruses binding to MHC-II proteins. If successful, this fundamental science will reveal the molecular pathways behind receptor tropism shifts. That knowledge could enable more informed monitoring of emerging viruses with pandemic potential, helping public health systems spot dangerous receptor changes before they cause widespread outbreaks. While the work is curiosity-driven, similar fundamental studies of viral entry mechanisms have previously underpinned the development of antiviral drugs and vaccine designs.

View original technical description
Viruses typically employ either glycans or proteins as receptors. However, certain viruses, such as influenza A and coronaviruses, have the ability to alter their receptor specificity—from a glycan to a protein receptor, and in some instances, even bind both. These receptor transitions can correlate with changes in viral tropism, influencing disease severity and facilitating host jumps. Yet, little is known about the effects the receptor type have on the mechanism of viral entry. I will use my background in studying the structure and evolution of viral glycoproteins to compare at the molecular level how different receptor types are recognised structurally, how they dictate interaction avidity, and affect the mechanisms of viral fusion. We will build on my pilot data on interactions between haemagglutinins of bat-like influenza viruses and their non-canonical protein receptors MHC-IIs, and new structural insights into coronavirus spikes, to investigate and compare mechanisms of binding between influenza haemagglutinins and coronavirus spikes with glycan and protein receptors. This will bring new insights into the mechanisms of viral entry and reveal possible evolutionary pathways associated with changes in receptor tropism, enabling informed monitoring of emerging viruses and contributing to pandemic prevention.

View the original record at the funder ↗

Researchers

Antoni Wrobel (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

How viruses switch between glycan and protein receptors and what it means for past and future pandemics
How Did Influenza Virus Evolve To Use A Novel Receptor Protein In Bats?
Improving Modern Influenza Virus Propagation by Engineering Glycan Expression
Synthetic glycolipids to investigate the interactome of viral glycan-binding proteins
The Language of Zoonosis: Rationalising Receptor-Mediated Spillover of Viral Pathogens at a Molecular Level

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.